Phase 2 Dengue Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Adaptive Dengue Antiviral Platform Trial
DengueAntiviral Drugs
Oxford University Clinical Research Unit, Vietnam500 enrolled2 locationsNCT06551844
Recruiting
Phase 2
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Dengue
Novartis Pharmaceuticals108 enrolled23 locationsNCT06006559
Recruiting
Phase 2
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
Dengue Fever
George Washington University74 enrolled2 locationsNCT04597437
Recruiting
Phase 2Phase 3
Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
DengueMontelukastTransaminases
Phramongkutklao College of Medicine and Hospital82 enrolled1 locationNCT06747130